Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sample Size Calculation01:19

Sample Size Calculation

3.3K
Knowledge of the sample size is the first requirement to conduct random sampling or an experiment. The sample size is the total number of units, observations, or groups (in some cases) used to get the data to estimate a population parameter. As the name suggests, the sample size is that of the sample drawn from the population and differs from the population size.
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
3.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

256
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
256
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

371
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
371
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

981
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
981

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multiple Testing of Mix-and-Match Feature Sets in Multi-Omics.

Statistics in medicine·2026
Same author

Temporal Dynamics of Neural Response to Drug Cues in abstinent Methamphetamine Users.

Basic and clinical neuroscience·2024
Same author

A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)·2023
Same author

The individual-level surrogate threshold effect in a causal-inference setting with normally distributed endpoints.

Pharmaceutical statistics·2021
Same author

Pathway testing for longitudinal metabolomics.

Statistics in medicine·2021
Same author

Inflated false discovery rate due to volcano plots: problem and solutions.

Briefings in bioinformatics·2021

相关实验视频

Updated: Jul 3, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

在药物相互作用试验中的样本大小计算上.

Paul Meyvisch1, Mitra Ebrahimpoor2

  • 1I-BioStat, Universiteit Hasselt, Diepenbeek, Belgium.

Pharmaceutical statistics
|February 15, 2024
PubMed
概括

药物相互作用试验的样本大小的计算可以简化. 一种新的基于精度的方法需要更少的参与者,并考虑潜在的相互作用,提高药物开发效率.

科学领域:

  • 药理动力学和药物开发
  • 临床试验设计 临床试验设计
  • 药理学中的统计方法学.

背景情况:

  • 药物相互作用 (DDI) 试验对于评估同时服用药物的风险和益处至关重要.
  • 传统的DDI样本大小计算依赖于难以定义的无效果边界,往往导致过于保守的估计和大样本大小.
  • 当先前的证据表明可能存在轻度或中度相互作用时,现有的方法是不够的,需要影响边界.

研究的目的:

  • 为DDI试验引入一种新的基于精度的样本大小计算方法.
  • 与传统的无效果边界方法相比,提供一种更有效和更具适应性的方法.
  • 为了考虑药物动力学变异性和预期的相互作用边界.

主要方法:

  • 开发了一个基于精度的样本大小计算框架.
  • 将静态药理动力学参数纳入计算中.
  • 考虑了潜在的无效或效果边界的宽度.

主要成果:

  • 提出的基于精度的方法需要更小的样本大小.
  • 该方法表现出有利的操作特征.
  • 一个涉及他类药物的案例研究说明了实际应用和益处.
关键词:
药物相互作用 药物相互作用精确的精确度可以说是精确的.

更多相关视频

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

相关实验视频

Last Updated: Jul 3, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

结论:

  • 基于精度的样本大小计算为DDI试验提供了更有效和更实用的方法.
  • 这种方法在处理药物动力学变异性和已知的或预期的相互作用时是有利的.
  • 该方法可以通过优化样本大小要求来简化药物开发.